The Effects of Patient Features on Opioid Induced End-Tidal CO2 (Capno)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Wayne Triner, Albany Medical College
ClinicalTrials.gov Identifier:
NCT01371903
First received: June 10, 2011
Last updated: March 20, 2014
Last verified: June 2011
  Purpose

Emergency department patients receiving opioid pain medicine such as morphine, fentanyl or Dilaudid are eligible. After medication exhaled carbon dioxide is measured. and recorded.


Condition
Opioid Use During Medical Care

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Effect of Patient Features on Opioid Induced End-Tidal CO2

Further study details as provided by Albany Medical College:

Primary Outcome Measures:
  • end tidal carbon dioxide [ Time Frame: study start, 30 minutes, 60 minutes, 90 minutes, 120 minutes ] [ Designated as safety issue: No ]
    measured through small nasal cannula (plastic tube at base of nares)


Enrollment: 278
Study Start Date: August 2010
Study Completion Date: November 2012
Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Detailed Description:

Emergency department patients receiving opioid pain medicine such as morphine, fentanyl, or Dilaudid are eligible. After receiving the pain medication, a small soft plastic tube will be placed between the upper lip and nose. This tube is used to measure the amount of carbon dioxide the patient is breathing out. It can also be used to deliver oxygen if the provider feels the patient needs it. The carbon dioxide breathed out is measured and collected. Other information collected are height, weight, and vital signs. Patient participation time is approximately 2 hours during the emergency department visit.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients receiving opioid such as morphine, fentanyl, or dilaudid during their emergency department visit.

Criteria

Inclusion Criteria:

  • non intubated patients receiving intravenous opioid medications

Exclusion Criteria:

  • mechanically ventilated patients
  • patients with physiologic shock
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01371903

Locations
United States, New York
Albany Medical Center Emergency Department
Albany, New York, United States, 12208
Sponsors and Collaborators
Albany Medical College
  More Information

No publications provided

Responsible Party: Wayne Triner, Professor Emergency Medicine, Albany Medical College
ClinicalTrials.gov Identifier: NCT01371903     History of Changes
Other Study ID Numbers: 2792
Study First Received: June 10, 2011
Last Updated: March 20, 2014
Health Authority: United States: AMC Institutional Review Board

Keywords provided by Albany Medical College:
morphine
fentanyl
dilaudid
opioid
capnography

Additional relevant MeSH terms:
Analgesics, Opioid
Narcotics
Central Nervous System Depressants
Physiological Effects of Drugs
Pharmacologic Actions
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on August 21, 2014